발효굴추출물의 경구 섭취가 소아 신장 성장에 미치는 효과 및 안전성 평가를 위한 무작위배정, 이중눈가림, 위약 대조 인체적용시험: 인체적용시험 프로토콜
Randomized, Double-blind, and Placebo-controlled a Human Study for Growing of Stature via the Analysis of Effect of Ferment Oyster Extract: Study Protocol
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: The purpose of this study is to confirm the efficacy and safety of the treatment of with fermented oyster extract on height growth in children with short stature. Methods: A total of 100 people, between 6 and 11 years old, will be participated in a randomized, double-blind, and placebo-controlled human study. The fermented oyster group will take 500 mg of fermented oyster extract once a day for 24 weeks. The placebo group will take 3400 mg of fructooligosaccharide as placebo once a day for 24 weeks. The outcomes of the intervention will be measured at the baseline, 6 week, 12 week, 18 week, and 24 week. The primary outcome is the changes in height from the baseline. The secondary outcomes are growth rate, height SDS, bone age, GH, IGF-1, IGFBP-3, osteocalcin, BALP, DPD, and LH. Results: This trial was approved by the institutional review board of Pusan National University Korean Medicine Hospital (registry number: PNUKHIRB-2019002). Recruitment of the research participants will be opened from May 2019 till December 2019. Conclusions: This study will provide clinical information to determine the efficacy and safety of the treatment with fermented oyster extract on height growth in children with short stature
Abstract
Objectives: The purpose of this study is to confirm the efficacy and safety of the treatment of with fermented oyster extract on height growth in children with short stature. Methods: A total of 100 people, between 6 and 11 years old, will be participated in a randomized, double-blind, and placebo-controlled human study. The fermented oyster group will take 500 mg of fermented oyster extract once a day for 24 weeks. The placebo group will take 3400 mg of fructooligosaccharide as placebo once a day for 24 weeks. The outcomes of the intervention will be measured at the baseline, 6 week, 12 week, 18 week, and 24 week. The primary outcome is the changes in height from the baseline. The secondary outcomes are growth rate, height SDS, bone age, GH, IGF-1, IGFBP-3, osteocalcin, BALP, DPD, and LH. Results: This trial was approved by the institutional review board of Pusan National University Korean Medicine Hospital (registry number: PNUKHIRB-2019002). Recruitment of the research participants will be opened from May 2019 till December 2019. Conclusions: This study will provide clinical information to determine the efficacy and safety of the treatment with fermented oyster extract on height growth in children with short stature
참고문헌 (42)
- Rona RJ, "Genetic and environmental influences on growth", J Med Screen, 2(3), pp.133~139 (1995)
- 이기형, "소아의 성장평가 및 성장장애의 진단", Clinical and Experimental Pediatrics, 46(12), pp.1171~1177 (2003), 대한소아청소년과학회
- Rosenfeld RG, "Pediatric Endocrinology", pp.116~169 (2002), WB Saunders Co
- 김지은, "소아 성장을 위한 한약 투여에 대한 후향적 연구", 대한한방소아과학회지, 30(4), pp.87~98 (2016), 대한한방소아과학회
- 윤혜준, "소아의 성장과 한방치료에 대한 부모들의 인식조사", 대한한방소아과학회지, 25(1), pp.119~127 (2011), 대한한방소아과학회
- 허경, "대학병원 성장클리닉을 내원한 아동에서 설문 조사를 통한 키성장 관리 실태분석", Clinical and Experimental Pediatrics, 52(5), pp.576~580 (2009), 대한소아청소년과학회
- Wang BY, "Chinese Pediatrics", pp.34~35 (1996), Eui Seong Dang Publishing Co
- "Korean Traditional Knowledge Portal. Molyeoyug" (2007)[URL]
- Kenji Osaki, "알코올로 유도된 간 손상 동물모델에서 굴 추출물의 간 보호 효과", 한국식품영양과학회지, 45(6), pp.805~811 (2016), 한국식품영양과학회
- Jeong EJ, "Effects of oral taurine supplementation on blood antioxidant enzyme activities and lipid peroxidation in healthy female adults", J Korean Nutr Soc, 33(7), pp.745~754 (2000)
- 강소영, "타우린 섭취 후 경락마사지가 중년여성의 혈중피로·항산화물질 및 호르몬에 미치는 영향", 한국인체미용예술학회지, 16(2), pp.7~25 (2015), 한국인체미용예술학회
- 이윤경, "운동전 타우린 섭취가 당뇨 유발쥐의 지질대사, 글리코겐 함량 및 항산화체계에 미치는 영향", 한국체육학회지, 46(2), pp.461~471 (2007), 한국체육학회
- 조은소리, "고온 스트레스 하에 타우린 첨가가 육계 간의 Heat Shock Protein 70 및In Vitro의 단백질 합성에 미치는 영향", 한국가금학회지, 43(4), pp.213~218 (2016), 한국가금학회[DOI]
- 최미자, "타우린 첨가 식이가 흰쥐에서 혈중 지질과 간 지질 농도에 미치는 영향", 동아시아식생활학회지, 16(2), pp.121~127 (2006), 동아시아식생활학회
- 윤진아, "사람의 체내에서 타우린의 역할에 관한 연구", 한국식품영양학회지, 28(5), pp.880~893 (2015), 한국식품영양학회
- 우남식, "굴(Crassostrea gigas)·다시마(Saccharina japonica) 발효분말의 스트레스 완화 및 수면 유도 효과", 한국수산과학회지, 46(6), pp.702~707 (2013), 한국수산과학회
- Cavagnini F, "Effect of acute and repeated administration of gamma aminobutyric acid(GABA)on growth hormone and prolactin secretion in man", Acta Endocrinol(Copenhagen), 93(2), pp.149~154 (1980)
- Powers M, "GABA supplementation and growth hormone response", Med Sport Sci, 59, pp.36~46 (2012)
- Lee DH, "Effects of astragalus extract mixture HT042 on height growth in children with mild short stature: A multicenter randomized controlled trial", Phytother Res, 32(1), pp.49~57 (2018)
- Hong CU, "Pediatrics", pp.10~12 (2016), Miraen
- Ranke MB, "Towards a consensus on the definition of idiopathic short stature", 45(Suppl 2), pp.64~66 (1996)
- Woelfle J, "Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation", J Biol Chem, 278(1), pp.51261~ (2003)
- 김호성, "성장장애에서 인슐린양 성장인자와 인슐린양 성장인자 결합단백질의 역할", Endocrinology and Metabolism, 18(6), pp.543~551 (2003), 대한내분비학회
- Kawai M, "Unfavorable effects of growth hormone therapy on the final height of boy with short stature not caused by growth hormone deficiency", J Pediatr, 130(2), pp.205~209 (1997)
- 양세원, "최근 성장장애에서 성장호르몬 치료", Endocrinology and Metabolism, 18(6), pp.561~570 (2003), 대한내분비학회
- Lee BJ, "Protective effect of fermented sea tangle against ethanol and carbon tetrachloride-induced hepatic damage in Sprague-Dawley rats", Food Chem Toxicol, 48, pp.1123~1128 (2010)
- Inoue K, "Blood-pressure-lowering effect of a novel fermented milk containing γ-aminobutyric acid(GABA)in mild hypertensives", Eur J Clin Nutr, 57(3), pp.490~495 (2003)
- Lee BJ, "Antioxidant activity and γ-aminobutyric acid (GABA) content in sea tangle fermented by Lactobacillus brevis BJ20 isolated from traditional fermented foods", Food Chem, 122(1), pp.271~276 (2010)
- Okai Y, "Identification of heterogenous antimutagenic activities in the extract of edible brown seaweeds, Laminaria japonica (Makonbu) and Undaria pinnatifida (Wakame) by the umu gene expression system in Salmonella typhimurium (TA1535", pSK100 2), 1993, pp.303(2), 63~70
- Witkowska-Sedek E, "Relationship between 25(OH)D and IGF-I in children and adolescents with growth hormone deficiency", Adv Exp Med Biol, 912, pp.43~49 (2016)
- 최욱철, "Effects of γ-aminobutyric acid-enriched fermented sea tangle (Laminaria japonica) on brain derived neurotrophic factor-related muscle growth and lipolysis in middle aged women", ALGAE, 31(2), pp.175~187 (2016), 한국조류학회I[DOI]
- Sakashita M, "Oral Supplementation using gamma-aminobutyric acid and whey protein improves whole body fat-free mass in men after resistance training", J Clin Med Res, 11(6), pp.428~434 (2019)
- Ihn HJ, "Fermented oyster extract prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis", Nutrients, 11(6), pp.1392~ (2019)
- Jeong JW, "Protective effects of fermented oyster extract against RANKL-induced osteoclastogenesis through scavenging ROS generation in RAW 264.7 Cells", Int J Mol Sci, 20(6), pp.1439~ (2019)
- 정은진, "소아의 키 성장에 대한 성장호르몬의 치료효과", 약 학 회 지, 60(4), pp.211~221 (2016), 대한약학회
- "Korea Centers for Disease Control and Prevention"[URL]
- "Global database on child growth and malnutrition" (1997)[URL]
- Jeon JK, "Normative data on serum levels of IGF-I, IGFBP-3 in healthy korean children: effect of age sex, height, body mass index, and pubertal maturation on the serum levels", J Korean Soc Pediatr Endocrinol, 5(1), pp.75~82 (2000)
- Juul A, "Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3", J Clin Endocrinol Metab, 82(4), pp.1195~1201 (1997)
- Kannisto S, "Biochemical markers of bone metabolism in relation to adrenocortical and growth suppression during the initiation phase of inhaled steroid therapy", Pediatr Res, 52(2), pp.258~262 (2002)
- Johansen JS, "Serum bone Gla-protein as a marker of bone growth in children and adolescents : correlation with age, height, serum insulin-like growth factor I, and serum testosterone", J Clin Endocrinol Metab, 67(2), pp.273~278 (1988)
- Crofton PM, "Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type I collagen, and their interrelationships in schoolchildren", Clin Chem, 43(9), pp.1577~1581 (1997)
